2021 and beyond with Destiny Pharma's CEO, Neil Clark & CFO Shaun Claydon

0 views
Author: Vox Markets

Management of Destiny Pharma, the AIM listed infection prevention biotechnology company, offer an overview of the Company, their platform and their late stage clinical assets heading towards phase 3 trails. The team expand on the anti infective market, their COVID 19 program and the strength of …

Read more
money
shares
stocks
investing
trading
Company News
Financial News
London Stock Exchange
Vox Markets
small caps investing
small caps
Trellus Health
TRLS
Powered bySeeen logo